Skip to main content

Table 2 Baseline demographic and clinical characteristics, split by group

From: Two weeks of twice-daily prism adaptation treatment does not improve posture or gait in Parkinson’s disease: a double-blind randomized controlled trial

 

Reala

Shama

Comparison

N

16

13

 

Sex (% females)

31.3

53.8

bp=.19

Age (years)

70.8 (7.9)

68.3 (8.2)

t(27)=0.83, p=.41

Handedness (% left)

0.0

23.1

Χ2(29)=4.1, p=.042c

Time since diagnosis (years)

7.5 (5.8)

7.7 (5.3)

t(27)=0.14, p=.89

Weight (pounds)

171.0 (58.5)

159.9 (38.2)

t(27)=0.59, p=.56

Height (inches)

66.6 (4.4)

66.5 (5.1)

t(27)=0.01, p=.99

MOCA (/30)

24.7 (0.5)

26.5 (3.0)

t(27)=1.5, p=.15

MDS-UPDRS-III

 Gait (/4)

1 (1)

1 (2)

U(29)= 84.5, p=.31

 Freezing (/4)

0 (1)

1 (0.5)

U(29)= 87.5, p=.48

 Postural stability (/4)

1 (0.75)

1.0 (1.0)

U(29)= 83, p=.37

 Total (/132)

34.3 (9.9)

33.5 (14.7)

t(27)=0.12, p=.87

Hoehn and Yahn

2.25 (1)

2.5 (1)

U(29)= 89.5, p=.53

TUAG (s)

11.6 (5.0)

9.9 (3.0)

t(27)=0.93, p=.26

  1. Abbreviations: MDS-UPDRS-III, Movement Disorder Society Unified Parkinson’s Disease Rating Scale section three; MOCA, Montreal Cognitive Assessment; TUAG, Timed Up and Go. aSummary statistics indicate percentage, mean (standard deviation), or median (interquartile range). bFisher’s exact test. cSignificant